SIBO in patients with CD is related with more severe diseaseEradication of SIBO using rifaximin reduced symptoms of IBDIn IBD patients, SIBO increases blood endotoxin, TLR2, and TLR4 levels, mediating body inflammationPatients with UC easily experience SIBO. This evidence concerns the gene TLR2 and inflammatory bowel disease.